How Companies in South Africa Can Source Pharma Products & CDMO Services (2026 Guide)
South Africa • Source Pharma Products & CDMO Services
Introduction
South Africa has the most developed pharmaceutical market in sub-Saharan Africa. It combines a large private sector, a public health system that serves most of the population, and a local manufacturing base that still relies on imported APIs and many finished products.
Buyers include distributors, pharmacy groups, hospital networks, local manufacturers and companies bidding on public tenders. This guide explains where supply typically comes from, what South African buyers source, how to qualify a manufacturer or CDMO, which import documents you need, and how the South African Health Products Regulatory Authority (SAHPRA) shapes each step.
Where supply comes from
No single country covers everything a South African buyer needs. Most portfolios draw on several supply bases, chosen by product type, regulatory track record and cost.
Main supply bases
- India and China: the main sources of generic APIs and intermediates. India also supplies a large share of finished generics, including many antiretrovirals and TB medicines used in public programmes.
- Europe (EU-GMP): complex generics, sterile injectables, biologics and specialty hospital products, often with dossiers already reviewed by stringent regulators.
- United States: specialty products, biologics and some niche generics.
- Africa: local manufacturing in South Africa itself, plus regional producers in Kenya, Egypt and Morocco for selected generics and consumer health lines.
What decides the choice
For most buyers, three questions matter most. Has the site passed inspections SAHPRA can rely on? Is there a registration-ready dossier? Can the supplier hold steady volumes over a two- or three-year contract? Price matters, but a low offer without a usable dossier rarely reaches the market.
Pharma categories supply
Demand reflects a high burden of HIV and TB alongside rising rates of diabetes, hypertension and other chronic conditions.
| Category | Typical products | Common supply base |
|---|---|---|
| Chronic generics | Antihypertensives, antidiabetics, statins, proton pump inhibitors | Asia, with some European supply |
| HIV and TB medicines | Fixed-dose ARV combinations, TB regimens | WHO-prequalified generic sites, mostly in Asia |
| Sterile injectables | Antibiotics, oncology vials, lyophilised products, IV fluids | EU-GMP and other inspected sterile sites |
| Biologics and specialty | Insulin, biosimilars, oncology | Europe, the US and selected Asian sites |
| APIs and intermediates | Bulk APIs for local formulation | China and Asia broadly, Europe for niche APIs |
| OTC and complementary medicines | Vitamins, cold and flu, supplements | Contract manufacturers worldwide and local producers |
CDMO and contract services
Local brand owners also outsource tablet, capsule, liquid and sterile manufacturing, contract packaging and dossier development. This is common when a company wants to launch faster than building its own capacity would allow.
How to source pharma products
- Write a clear brief. List the molecule, strength, dosage form, pack size, annual volume, target channel (private, tender or both) and whether you need a registered product or a dossier to file yourself.
- Shortlist qualified sites. Look for WHO prequalification, EU-GMP, US FDA or PIC/S inspection history. SAHPRA is a PIC/S member and uses reliance on recognised regulators, so these inspections carry real weight.
- Verify documents. Check the GMP certificate against the issuing authority's records, and request a WHO-format COPP, CoAs for recent batches and stability data that supports South African storage conditions.
- Review the dossier. SAHPRA works in the CTD format and accepts eCTD. Ask for a gap analysis against SAHPRA guidelines before you sign, not after.
- Agree commercial terms. Cover MOQ, price basis (FCA, CIF or DAP), lead times, artwork ownership, exclusivity and a quality agreement.
- Run a pilot order. Test documents, labelling and the cold chain on a small batch before committing to tender volumes.
PharmaTradz lets buyers post a requirement and compare responses from GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. Start with a request for quotation, and use our guide on how to verify a pharmaceutical supplier to check each offer.
Required documents for import
Regulatory and quality documents
- SAHPRA registration for the product, or a Section 21 authorisation for an unregistered medicine
- The importer's SAHPRA licence issued under Section 22C of the Medicines and Related Substances Act
- An import permit from SAHPRA for controlled substances such as narcotics and psychotropics
- GMP certificate for the manufacturing site
- Batch Certificate of Analysis
- Certificate of Pharmaceutical Product (COPP) where relevant
Commercial and shipping documents
- Commercial invoice and packing list
- Bill of lading or air waybill
- Certificate of origin
- Temperature records for cold-chain cargo
- Customs declaration lodged with the South African Revenue Service (SARS) through a licensed clearing agent
Keep batch numbers identical across the CoA, invoice and packing list. Mismatches are one of the most common causes of delay at the port.
Logistics and shipping
Main entry points
- Sea: Durban, the country's busiest container port, followed by Cape Town and Port Elizabeth/Ngqura in Gqeberha.
- Air: O.R. Tambo International in Johannesburg handles most pharmaceutical air cargo, with Cape Town International and King Shaka International in Durban as alternatives.
Indicative transit times
| Origin | Sea freight | Air freight |
|---|---|---|
| Asia | Typically 2–4 weeks port to port | Typically 3–6 days |
| Europe | Typically 3–5 weeks port to port | Typically 2–4 days |
Allow extra time for customs clearance, port congestion at Durban and road transport to Gauteng.
Cold chain and Incoterms
Insulin, vaccines, biologics and many injectables need 2–8°C handling with validated packaging and temperature loggers. Use GDP-compliant forwarders and agree who carries the risk of a temperature excursion at each handover.
Most buyers buy on FCA or CIF for sea cargo, and use DAP or DDP only when the supplier has a reliable local agent. For specialist support, see our cold chain pharma logistics service.
Legal and regulatory overview
The regulator
SAHPRA regulates medicines, complementary medicines and medical devices under the Medicines and Related Substances Act 101 of 1965. It replaced the Medicines Control Council in 2018.
Registration basics
- The applicant and holder of registration must be a company based in South Africa. Foreign manufacturers work through a local holder.
- Dossiers follow the CTD format, and SAHPRA accepts eCTD submissions.
- The patient information leaflet must be in English and at least one other official language.
- Reliance pathways can shorten review for products already approved by recognised regulators.
- Private-sector medicine prices are controlled through the Single Exit Price system.
Section 21: access to unregistered medicines
Section 21 of the Act allows SAHPRA to authorise the sale or use of an unregistered medicine for a defined purpose, such as named patients or a supply gap. Each authorisation is specific to the product and purpose and comes with conditions. It is not a substitute for registration.
Public tenders
The national Department of Health buys most public-sector medicines through national contracts. Bidders typically need a registered product, and bids are scored on price and preference points under South African procurement law. See our government tender supply service.
Regional and global context
South Africa takes part in the ZaZiBoNa collaborative assessment in SADC, part of the AMRH harmonisation effort. The African Medicines Agency, based in Kigali, is building continent-wide procedures. WHO prequalification remains important for HIV, TB and malaria products in donor-funded programmes.
Common challenges and practical solutions
| Challenge | Practical solution |
|---|---|
| Long registration timelines | Prioritise products already approved by a recognised regulator or WHO-prequalified, so SAHPRA reliance can apply. File a complete, quality-checked dossier. |
| Dossier gaps | Run a gap analysis against SAHPRA guidelines before signing, and budget for extra bioequivalence or stability work. |
| Labelling errors | Build artwork from the approved professional information and leaflet, and check the second language early. |
| Supply gaps during registration | Use Section 21 only where it fits the rules, and plan launches around realistic timelines. |
| Port and customs delays | Use an experienced clearing agent, align batch numbers on all documents and pre-lodge declarations. |
| Currency swings | Agree prices in a stable currency with review clauses, or hedge larger orders. |
If you need help preparing or filing a dossier, see our dossier licensing and registration service.
Conclusion
South African buyers get the best results when they treat sourcing as a regulatory project as much as a purchasing one. Choose manufacturers whose inspections and dossiers SAHPRA can rely on, plan around registration and Section 21 rules, and set up cold chain and clearing before the first shipment.
PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa and can help you compare options. For more market context, visit our South Africa country hub.
Frequently Asked Questions
Who can hold a medicine registration in South Africa?
The applicant must be a company based in South Africa. A foreign manufacturer appoints a local holder, which takes responsibility for quality, safety reporting and recalls.
Can I import an unregistered medicine into South Africa?
Only with a Section 21 authorisation from SAHPRA. It is granted for a specific product and purpose, with conditions attached.
Does SAHPRA accept GMP inspections by other regulators?
SAHPRA is a PIC/S member and uses reliance on recognised regulators, but it can still inspect a site or ask for more information.
Which ports handle most pharmaceutical imports?
Durban handles most sea freight, and O.R. Tambo International in Johannesburg handles most air cargo.
Are medicine prices regulated in South Africa?
Yes. The Single Exit Price system sets one price that a manufacturer or importer charges all private-sector buyers, with adjustments approved by government.
Do public tenders require WHO prequalification?
SAHPRA registration is the baseline for national contracts. WHO prequalification matters mainly for donor-funded HIV, TB and malaria supply.
Source Pharma Products & CDMO Services — other markets
Planning to register or source in South Africa?
Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.
Submit a Requirement Ask a questionIf you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying South Africa than you probably think.
South Africa's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
